Greg Watanabe, PharmD Candidate

Erlotinib taken with gemcitabine was approved by the FDA for locally advanced, inoperable, or metastatic pancreatic cancer in 2005.

Many companies are working with health systems to transition patients from the hospital to in-home care as quickly as possible.